Genotypically distinct Leishmania colombiensis isolates from Venezuela cause both cutaneous and visceral leishmaniasis in humans

Author： Rodriguez-Bonfante C.   Bonfante-Garrido R.   Grimaldi G.   Momen H.   Cupolillo E.  

Publisher： Elsevier

ISSN： 1567-1348

Source： Infection, Genetics and Evolution, Vol.3, Iss.2, 2003-07, pp. : 119-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

By Paraguai de Souza E.   Bernardo R.R.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3104-3115

Elsevier

Access to resources Recommend Favorite

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani

By Santos W.R.   Paraguai de Souza E.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2554-2561

Elsevier

Access to resources Recommend Favorite

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis

By Gonzalo R.M.   del Real G.   Rodriguez J.R.   Rodriguez D.   Heljasvaara R.   Lucas P.   Larraga V.   Esteban M.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1226-1231

Elsevier

Access to resources Recommend Favorite

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

By Rafati S.   Salmanian A.-H.   Taheri T.   Vafa M.   Fasel N.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3369-3375

Elsevier

Access to resources Recommend Favorite

Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis

By Pinto E.F.   de Mello Cortezia M.   Rossi-Bergmann B.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3534-3541

Elsevier

Access to resources Recommend Favorite